Skip to main content

Advertisement

SpringerLink
Log in

Resective epilepsy surgery: assessment of randomized controlled trials

  • Review
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

Epilepsy is the most common form of chronic neurologic disease. Here, we review the available randomized controlled trials (RCTs) that examined the efficacy of resective epilepsy surgery in select patients suffering from medically intractable epilepsy (defined as persistent epilepsy despite two or more antiepileptic drugs [AEDs]). Three RCTs (two adult RCTs and one pediatric RCT) consistently supported the efficacy of resective surgery as treatment for epilepsy with semiology localized to the mesial temporal lobe. In these studies, 58–100% of the patients who underwent resective surgery achieved seizure freedom, in comparison to 0–13% of medically treated patients. In another RCT, the likelihood of seizure freedom after resective surgery was independent of the surgical approach (transSylvian [64%] versus subtemporal [62%]). Two other RCTs demonstrated that hippocampal resection is essential to optimize seizure control. But, no significant gain in seizure control was achieved beyond removing 2.5 cm of the hippocampus. Across RCTs, minor complications (deficit lasting < 3 months) and major complications (deficit > 3 months) ranged 2–5% and 5–11% respectively. However, nonincapacitating superior subquadrantic visual-field defects (not typically considered a minor or major complication) were noted in up to 55% of the surgical cohort. The available RCTs provide compelling support for resective surgery as a treatment for mesial temporal lobe epilepsy and offer insights toward optimal surgical strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D (1997) Quality of life of people with epilepsy: a European study. Epilepsia 38:353–362. https://doi.org/10.1111/j.1528-1157.1997.tb01128.x

    Article  CAS  PubMed  Google Scholar 

  2. Boylan LS, Flint LA, Labovitz DL, Jackson SC, Starner K, Devinsky O (2004) Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 62:258–261. https://doi.org/10.1212/01.wnl.0000103282.62353.85

    Article  CAS  PubMed  Google Scholar 

  3. De Tisi J, Bell GS, Peacock JL, McEvoy AW, Harkness WF, Sander JW, Duncan JS (2011) The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet 378:1388–1395. https://doi.org/10.1016/S0140-6736(11)60890-8

    Article  PubMed  Google Scholar 

  4. Devinsky O, Vezzani A, O’Brien TJ, Jette N, Scheffer IE, de Curtis M, Perucca P (2018) Epilepsy Nat Rev Dis Prim 4:18024. https://doi.org/10.1038/nrdp.2018.24

    Article  PubMed  Google Scholar 

  5. Dwivedi R, Ramanujam B, Chandra PS, Sapra S, Gulati S, Kalaivani M, Garg A, Bal CS, Tripathi M, Dwivedi SN, Sagar R, Sarkar C, Tripathi M (2017) Surgery for Drug-Resistant Epilepsy in Children. N Engl J Med 377:1639–1647. https://doi.org/10.1056/NEJMoa1615335

    Article  PubMed  Google Scholar 

  6. Engel J, McDermott MP, Wiebe S, Langfitt JT, Erba G, Gardiner I, Stern J, Dewar S, Sperling MR, Jacobs M, Kieburtz K, Early Randomized Surgical Epilepsy Trial (ERSET) Study Group (2010) Design considerations for a multicenter randomized controlled trial of early surgery for mesial temporal lobe epilepsy. Epilepsia 51:1978–1986. https://doi.org/10.1111/j.1528-1167.2010.02641.x

    Article  PubMed  PubMed Central  Google Scholar 

  7. Engel J, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, Sperling MR, Gardiner I, Erba G, Fried I, Jacobs M, Vinters HV, Mintzer S, Kieburtz K, Early Randomized Surgical Epilepsy Trial (ERSET) Study Group (2012) Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA 307:922–930. https://doi.org/10.1001/jama.2012.220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hamid H, Blackmon K, Cong X, Dziura J, Atlas LY, Vickrey BG, Berg AT, Bazil CW, Langfitt JT, Walczak TS, Sperling MR, Shinnar S, Devinsky O (2014) Mood, anxiety, and incomplete seizure control affect quality of life after epilepsy surgery. Neurology 82:887–894. https://doi.org/10.1212/WNL.0000000000000183

    Article  PubMed  PubMed Central  Google Scholar 

  9. Harden CL, Maroof DA, Nikolov B, Fowler K, Sperling M, Liporace J, Pennell P, Labar D, Herzog A (2007) The effect of seizure severity on quality of life in epilepsy. EpilepsyBehav 11:208–211. https://doi.org/10.1016/j.yebeh.2007.05.002

    Article  Google Scholar 

  10. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC, Cochrane Bias Methods Group, Cochrane Statistical Methods Group (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https://doi.org/10.1136/bmj.d5928

    Article  PubMed  PubMed Central  Google Scholar 

  11. Jeha LE, Najm IM, Bingaman WE, Khandwala F, Widdess-Walsh P, Morris HH, Dinner DS, Nair D, Foldvary-Schaeffer N, Prayson RA, Comair Y, O’Brien R, Bulacio J, Gupta A, Lüders HO (2006) Predictors of outcome after temporal lobectomy for the treatment of intractable epilepsy. Neurology 66:1938–1940. https://doi.org/10.1212/01.wnl.0000219810.71010.9b

    Article  CAS  PubMed  Google Scholar 

  12. Jetté N, Sander JW, Keezer MR (2016) Surgical treatment for epilepsy: the potential gap between evidence and practice. Lancet Neurol 15:982–994. https://doi.org/10.1016/S1474-4422(16)30127-2

    Article  PubMed  Google Scholar 

  13. Jobst BC, Cascino GD (2015) Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA 313:285–293. https://doi.org/10.1001/jama.2014.17426

    Article  PubMed  Google Scholar 

  14. Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. N Engl J Med 342:314–319. https://doi.org/10.1056/NEJM200002033420503

    Article  CAS  PubMed  Google Scholar 

  15. Kwon CS, Blank L, Mu L, Jetté N (2020) Trends in lobectomy/amygdalohippocampectomy over time and the impact of hospital surgical volume on hospitalization outcomes: A population-based study. Epilepsia epi.16664. https://doi.org/10.1111/epi.16664

  16. Lee AT, Burke JF, Chunduru P, Molinaro AM, Knowlton R, Chang EF (2020) A historical cohort of temporal lobe surgery for medically refractory epilepsy: a systematic review and meta-analysis to guide future nonrandomized controlled trial studies. J Neurosurg 133:71–78. https://doi.org/10.3171/2019.4.JNS183235

    Article  Google Scholar 

  17. Liu G, Slater N, Perkins A (2017) Epilepsy: treatment options. Am Fam Physician 96:87–96

    PubMed  Google Scholar 

  18. McGovern RA, Banks GP, McKhann GM (2016) New techniques and progress in epilepsy surgery. CurrNeurolNeurosci Rep 16:65. https://doi.org/10.1007/s11910-016-0661-6

    Article  CAS  Google Scholar 

  19. Moshé SL, Perucca E, Ryvlin P, Tomson T (2015) Epilepsy: new advances. Lancet (London, England) 385:884–898. https://doi.org/10.1016/S0140-6736(14)60456-6

    Article  Google Scholar 

  20. Schramm J, Lehmann TN, Zentner J, Mueller CA, Scorzin J, Fimmers R, Meencke HJ, Schulze-Bonhage A, Elger CE (2011) Randomized controlled trial of 2.5-cm versus 3.5-cm mesial temporal resection in temporal lobe epilepsy–Part 1: intent-to-treat analysis. ActaNeurochir (Wien) 153:209–219. https://doi.org/10.1007/s00701-010-0900-6

    Article  Google Scholar 

  21. Seiam A-HR, Dhaliwal H, Wiebe S (2011) Determinants of quality of life after epilepsy surgery: systematic review and evidence summary. Epilepsy Behav 21:441–445. https://doi.org/10.1016/j.yebeh.2011.05.005

    Article  PubMed  Google Scholar 

  22. Simasathien T, Vadera S, Najm I, Gupta A, Bingaman W, Jehi L (2013) Improved outcomes with earlier surgery for intractable frontal lobe epilepsy. Ann Neurol 73:646–654. https://doi.org/10.1002/ana.23862

    Article  PubMed  Google Scholar 

  23. Stephen LJ, Brodie MJ (2002) Seizure freedom with more than one antiepileptic drug. Seizure 11:349–351. https://doi.org/10.1053/seiz.2002.0711

    Article  PubMed  Google Scholar 

  24. Vogt VL, Delev D, Grote A, Schramm J, von Lehe M, Elger CE, Witt J-A, Helmstaedter C (2018) Neuropsychological outcome after subtemporal versus transSylvian approach for selective amygdalohippocampectomy in patients with mesial temporal lobe epilepsy: a randomised prospective clinical trial. J Neurol Neurosurg Psychiatry 89:1057–1063. https://doi.org/10.1136/jnnp-2017-316311

  25. West S, Nevitt SJ, Cotton J, Gandhi S, Weston J, Sudan A, Ramirez R, Newton R (2019) Surgery for epilepsy. Cochrane database. Syst Rev 6:CD010541. https://doi.org/10.1002/14651858.CD010541.pub3

    Article  Google Scholar 

  26. Wiebe S, Blume WT, Girvin JP, Eliasziw M, Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group (2001) A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 345:311–318. https://doi.org/10.1056/NEJM200108023450501

    Article  CAS  PubMed  Google Scholar 

  27. Wyler AR, Hermann BP, Somes G (1995) Extent of medial temporal resection on outcome from anterior temporal lobectomy: a randomized prospective study. Neurosurgery 37:982–90; discussion 990–1. https://doi.org/10.1227/00006123-199511000-00019

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, University of Minnesota, 420 Delaware St SE, MMC 96, D-429 Mayo Memorial Building, Minneapolis, MN, 55455, USA

    Samuel W. Cramer, Robert A. McGovern, Clark C. Chen & Michael C. Park

  2. Department of Neurology, University of Minnesota, 516 Delaware St SE, 12-100 Phillips Wangensteen Building, Minneapolis, MN, 55455, USA

    Robert A. McGovern, Sonya G. Wang & Michael C. Park

Authors
  1. Samuel W. Cramer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert A. McGovern
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sonya G. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Clark C. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael C. Park
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samuel W. Cramer.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval and informed consent

This literature review did not involve direct human procedures. This article does not contain any studies with human participants performed by any of the authors. For this type of study, formal consent is not required.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cramer, S.W., McGovern, R.A., Wang, S.G. et al. Resective epilepsy surgery: assessment of randomized controlled trials. Neurosurg Rev 44, 2059–2067 (2021). https://doi.org/10.1007/s10143-020-01432-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10143-020-01432-x

Keywords

Search

Navigation